Ozempic Side Effects: Common, Serious & Long-Term Risks

Ozempic® (semaglutide) has become one of the most commonly prescribed medications for adults with type 2 diabetes because it can improve blood sugar control while also supporting meaningful weight loss for many people. Like all prescription medications, however, Ozempic can cause side effects ranging from mild digestive discomfort to rare but serious complications.

Most people experience only mild gastrointestinal symptoms—such as nausea, diarrhea, constipation, or vomiting—that gradually improve as the body adjusts to treatment. Less commonly, Ozempic may increase the risk of pancreatitis, gallbladder disease, severe allergic reactions, or kidney injury caused by dehydration. The medication also carries an FDA boxed warning regarding thyroid C-cell tumors based on findings in animal studies, although it is unknown whether this risk applies to humans.¹

This evidence-based guide explains the most common and serious Ozempic side effects, how they compare with Mounjaro® (tirzepatide), when symptoms should prompt medical attention, and practical strategies that may help reduce gastrointestinal discomfort while taking semaglutide.

What Are the Most Common Ozempic Side Effects?

Most Ozempic side effects affect the digestive system. The most frequently reported symptoms include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These symptoms are usually most noticeable during the first several weeks of treatment or after a dose increase and often improve over time.

Although uncommon, Ozempic can also cause serious side effects such as pancreatitis, gallbladder disease, kidney injury from dehydration, severe allergic reactions, diabetic retinopathy complications in some patients, and an FDA boxed warning regarding thyroid C-cell tumors. Contact your healthcare provider immediately if you develop severe abdominal pain, persistent vomiting, difficulty breathing, facial swelling, or a lump in your neck.¹ 

Key Takeaways

• Ozempic (semaglutide) is a once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes.
• The most common side effects are nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite.
• Most digestive symptoms improve within several weeks as your body adapts to treatment.
• Serious side effects are uncommon but include pancreatitis, gallbladder disease, kidney injury, severe allergic reactions, and worsening diabetic retinopathy in some patients.
• Ozempic carries an FDA boxed warning about thyroid C-cell tumors observed in rodents. It should not be used in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).¹
• Mounjaro and Ozempic share many of the same gastrointestinal side effects, although individual experiences vary.

Medical Guidelines at a Glance

Recommendation	Current Guidance
Medication Class	GLP-1 receptor agonist
FDA Approved For	Adults with type 2 diabetes, cardiovascular risk reduction in eligible patients, and certain adults with chronic kidney disease alongside diabetes1
Administration	Once-weekly subcutaneous injection
Most Common Side Effects	Nausea, vomiting, diarrhea, constipation, abdominal pain
Serious Risks	Pancreatitis, gallbladder disease, kidney injury, severe allergic reactions, diabetic retinopathy complications
FDA Boxed Warning	Thyroid C-cell tumors (animal studies)
Typical Symptom Timeline	Most digestive symptoms improve during dose titration over several weeks
Lifestyle Recommendations	Smaller meals, gradual dose increases, adequate hydration, balanced nutrition, regular follow-up with your healthcare provider

What Is Ozempic?

Ozempic® is the brand name for semaglutide, a prescription medication belonging to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is approved by the U.S. Food and Drug Administration (FDA) to improve blood glucose control in adults with type 2 diabetes when used together with healthy eating and regular physical activity. It is also approved to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of kidney disease progression and cardiovascular death in eligible adults with type 2 diabetes and chronic kidney disease.¹

Unlike insulin, Ozempic does not replace insulin production. Instead, it helps your body use its own natural hormones more effectively after meals. Because it also slows stomach emptying and helps people feel full sooner, many patients experience gradual weight loss while taking the medication.

Although Ozempic has become well known for its weight-loss effects, it is important to remember that it is FDA-approved for the treatment of type 2 diabetes, not as a standalone weight-loss medication. (Semaglutide is approved separately for chronic weight management under the brand name Wegovy®.)²

How Ozempic Works

Ozempic works by mimicking a naturally occurring hormone called GLP-1, which is released after eating. This hormone helps regulate blood glucose in several ways:

• Stimulates insulin release when blood sugar rises after meals.
• Reduces glucagon production, lowering the amount of glucose released by the liver.
• Slows stomach emptying, helping prevent rapid increases in blood sugar after eating.
• Increases feelings of fullness, which often reduces calorie intake and supports weight loss.

These combined effects improve A1C levels while reducing post-meal blood sugar spikes. Because stomach emptying slows, many of the medication’s most common side effects involve the digestive system, particularly during the first few weeks of treatment or after dose increases.¹

Common Ozempic Side Effects

Most people tolerate Ozempic well, but mild gastrointestinal symptoms are common, especially during dose escalation. According to the FDA prescribing information, the most frequently reported side effects occurring in at least 5% of patients include nausea, vomiting, diarrhea, abdominal pain, and constipation.¹

Most Frequently Reported Ozempic Side Effects

Side Effect	How Common	Usually Temporary?	Practical Tips
Nausea	Very common	Yes	Eat smaller meals, avoid greasy foods
Diarrhea	Common	Usually	Stay hydrated and eat bland foods
Constipation	Common	Usually	Increase fluids and dietary fiber gradually
Vomiting	Common	Usually	Sip fluids frequently and contact your provider if persistent
Abdominal pain	Common	Often	Eat slowly and avoid overeating
Decreased appetite	Common	Often	Focus on nutrient-dense meals and adequate protein

Many people notice that digestive symptoms are worst after starting Ozempic or increasing the weekly dose. In most cases, these symptoms gradually lessen as the digestive system adapts to the medication.

Why Does Ozempic Cause Digestive Side Effects?

The same mechanism that helps Ozempic improve blood sugar control also explains many of its side effects.

Because semaglutide slows the movement of food through the stomach, you may feel full sooner, eat less, or experience nausea after larger meals. This slower stomach emptying can also contribute to constipation, bloating, or occasional vomiting, particularly if meals are high in fat or eaten too quickly.

Fortunately, these symptoms are usually temporary.

When Do Ozempic Side Effects Start and How Long Do They Last?

Ozempic side effects often begin within the first few days after starting treatment or increasing the dose. Nausea, diarrhea, constipation, vomiting, and decreased appetite are usually most noticeable during the first several weeks.¹

For many people, these symptoms improve within 2 to 8 weeks as the body adjusts to semaglutide. Mild digestive symptoms may temporarily return after a dose increase.

Timeline	What to Expect
First few days	Nausea, reduced appetite, stomach discomfort
Weeks 1–4	Digestive side effects may be most noticeable
Weeks 4–8	Symptoms often begin improving
After dose increases	Temporary return of GI symptoms is possible

Persistent vomiting, severe abdominal pain, dehydration, sudden vision changes, or difficulty breathing should not be considered normal adjustment symptoms and require prompt medical attention.

Ozempic Side Effects Summary

Category	Common	Less Common	Serious (Seek Medical Care)
Digestive	Nausea, diarrhea, constipation, vomiting, abdominal pain	Heartburn, bloating	Severe persistent abdominal pain (possible pancreatitis)
Appetite	Reduced appetite	Taste changes	Excessive dehydration from prolonged vomiting
Allergic	Mild injection-site irritation	Rash	Facial swelling, difficulty breathing, anaphylaxis
Gallbladder	—	Gallstones	Cholecystitis requiring prompt evaluation
Kidneys	—	Dehydration	Acute kidney injury from severe fluid loss

Practical Tips to Reduce Ozempic Side Effects

Many people can significantly reduce gastrointestinal symptoms with a few simple lifestyle adjustments.

Eat Smaller Meals

Large meals place additional stress on a stomach that is already emptying more slowly. Eating smaller portions throughout the day is often easier to tolerate than three large meals.

Eat Slowly

Taking your time while eating allows your body’s fullness signals to catch up before you become overly full, which may reduce nausea.

Limit High-Fat Foods

Greasy or fried foods can worsen nausea and stomach discomfort. Choosing lean proteins, vegetables, fruit, and whole grains is often better tolerated.

Stay Well Hydrated

Vomiting or diarrhea can quickly lead to dehydration, increasing the risk of dizziness and kidney complications. Drink water regularly throughout the day and consider electrolyte-containing fluids if significant fluid losses occur.

Continue checking your blood sugar regularly while starting Ozempic, especially if you’re also taking insulin or a sulfonylurea. Our Blood Sugar Charts can help you interpret fasting and post-meal readings as you adjust to treatment.

Follow the Prescribed Dose Escalation Schedule

Ozempic doses are intentionally increased gradually to help your digestive system adjust. Avoid increasing your dose faster than recommended unless instructed by your healthcare provider.¹

Contact Your Healthcare Provider if Symptoms Persist

Persistent vomiting, inability to keep fluids down, severe abdominal pain, or symptoms lasting longer than expected should always be discussed with your healthcare provider. They may recommend slowing dose escalation, temporarily delaying a dose increase, or evaluating for another medical condition.

Serious Ozempic Side Effects

Although most people taking Ozempic experience only mild digestive symptoms, serious side effects can occur. These complications are uncommon but require prompt medical evaluation because delaying treatment may increase the risk of serious illness.

The FDA prescribing information warns about several important risks, including pancreatitis, gallbladder disease, acute kidney injury, diabetic retinopathy complications in some patients, severe allergic reactions, and a boxed warning regarding thyroid C-cell tumors.¹ Understanding these risks allows you to recognize warning signs early and seek appropriate medical care.

FDA Boxed Warning: Thyroid C-Cell Tumors

Ozempic carries the FDA’s strongest safety warning—a boxed warning—because semaglutide caused thyroid C-cell tumors in rodents during laboratory studies. Researchers do not know whether this same risk exists in humans, but the warning remains an important precaution.¹

For this reason, Ozempic should not be used if you:

• Have a personal history of medullary thyroid carcinoma (MTC)
• Have a family history of medullary thyroid carcinoma
• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Symptoms That Require Prompt Medical Attention

Contact your healthcare provider immediately if you develop:

• A lump or swelling in your neck
• Persistent hoarseness
• Difficulty swallowing
• Difficulty breathing
• Neck pain that does not improve

These symptoms do not necessarily mean thyroid cancer is present, but they should always be evaluated promptly.

Quick Fact: The boxed warning is based on findings from animal studies. Researchers have not establishedthat semaglutide causes thyroid cancer in humans, but avoiding the medication in high-risk individuals is recommended as a precaution.

Pancreatitis

Can Ozempic Cause Pancreatitis?

Yes. Although uncommon, acute pancreatitis has been reported in people taking Ozempic and other GLP-1 receptor agonists. Pancreatitis is inflammation of the pancreas and can become a medical emergency if left untreated.¹

Warning Signs

Seek immediate medical care if you experience:

• Severe upper abdominal pain
• Pain that radiates to your back
• Persistent nausea and vomiting
• Fever
• Abdominal tenderness
• Pain that continues for several hours

Unlike ordinary nausea that may occur when starting Ozempic, pancreatitis usually causes severe, persistent abdominal pain that does not improve after eating or resting.

If pancreatitis is suspected, Ozempic should be stopped while the cause is evaluated.¹ Your healthcare provider will determine whether treatment should be permanently discontinued.

Who May Be at Higher Risk?

Risk may be higher in people with:

• Previous pancreatitis
• Gallstones
• High triglyceride levels
• Heavy alcohol use

If you have any of these risk factors, discuss them with your healthcare provider before starting treatment.

Gallbladder Disease

GLP-1 medications, including Ozempic, have been associated with an increased risk of gallbladder problems such as:

• Gallstones (cholelithiasis)
• Gallbladder inflammation (cholecystitis)¹

Rapid weight loss itself may also contribute to gallstone formation, making it difficult to determine whether the medication, weight loss, or both are responsible.

Symptoms of Gallbladder Problems

Contact your healthcare provider if you develop:

• Pain in the upper right abdomen
• Pain after eating fatty meals
• Fever
• Chills
• Yellowing of the skin or eyes (jaundice)
• Persistent nausea or vomiting

Your provider may recommend blood tests or an ultrasound to evaluate your gallbladder if these symptoms occur.

Kidney Injury

Acute kidney injury associated with Ozempic has most often been reported in the setting of gastrointestinal symptoms that cause dehydration, such as prolonged nausea, vomiting, or diarrhea.¹

Symptoms of Dehydration

Watch for:

• Excessive thirst
• Dark-colored urine
• Dizziness
• Weakness
• Dry mouth
• Reduced urination

How to Reduce Your Risk

• Drink fluids regularly throughout the day.
• Replace fluids lost through vomiting or diarrhea.
• Contact your healthcare provider if you cannot keep liquids down.
• Follow your prescribed dose-escalation schedule to minimize digestive side effects.

People with chronic kidney disease should be monitored closely while taking Ozempic, especially during dose increases.

Vision Changes

Can Ozempic Affect Your Eyes?

Some people with diabetes experience temporary worsening of diabetic retinopathy after starting Ozempic, particularly if blood sugar improves very rapidly. This phenomenon has been observed with several diabetes treatments that produce significant reductions in A1C.

Importantly, Ozempic itself is not thought to directly damage the retina. Instead, rapid improvements in blood glucose may temporarily worsen existing diabetic eye disease before long-term stabilization occurs.¹

Contact Your Eye Doctor If You Notice:

• Blurred vision
• Floaters
• Dark spots
• Sudden vision loss
• Flashes of light
• Difficulty reading or focusing

People who already have diabetic retinopathy should continue regular dilated eye examinations and report any changes in vision promptly.

Clinical Note: The long-term benefits of improved glucose control generally outweigh the temporary risk of early worsening of diabetic retinopathy for most patients.

Severe Allergic Reactions

Serious allergic reactions (hypersensitivity) are rare but can occur with Ozempic.¹ These reactions require immediate emergency medical attention.

Symptoms Include

• Swelling of the face
• Swelling of the lips or tongue
• Swelling of the throat
• Difficulty breathing
• Difficulty swallowing
• Severe rash
• Hives
• Widespread itching

If you experience any of these symptoms, stop using Ozempic and seek emergency medical care immediately.

Mild Injection-Site Reactions

Some people notice:

• Mild redness
• Tenderness
• Itching
• Small swelling

These localized reactions usually improve within a few days and are not considered dangerous unless they continue to worsen.

When Should You Call Your Doctor?

Most Ozempic side effects improve as your body adjusts to treatment, but some symptoms should never be ignored.

Call Your Healthcare Provider Within 24 Hours If You Have:

Symptom	Possible Cause
Persistent nausea or vomiting	Dose intolerance or dehydration
Ongoing diarrhea	Fluid loss
Severe constipation	Gastrointestinal complication
Upper right abdominal pain	Gallbladder disease
New blurred vision	Diabetic retinopathy changes
Unable to eat or drink normally	Risk of dehydration

Seek Emergency Medical Care Immediately If You Have:

Symptom	Possible Emergency
Severe abdominal pain that radiates to your back	Pancreatitis
Difficulty breathing	Severe allergic reaction
Swelling of the face or throat	Anaphylaxis
Persistent vomiting with dizziness	Severe dehydration
Sudden vision loss	Eye emergency
Lump in the neck with difficulty swallowing	Thyroid evaluation needed

Quick Tip: If you’re unsure whether a symptom is serious, it’s safest to contact your healthcare provider. Early evaluation can help identify complications before they become emergencies.

Who Should Not Take Ozempic?

Ozempic is not appropriate for everyone. Before starting treatment, your healthcare provider will review your medical history to determine whether the medication is safe for you.

Ozempic Should Not Be Used If You:

• Have a personal history of medullary thyroid carcinoma (MTC)
• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Have had a serious allergic reaction to semaglutide or any ingredient in Ozempic¹

Talk With Your Healthcare Provider Before Starting Ozempic If You Have:

• A history of pancreatitis
• Gallbladder disease
• Chronic kidney disease
• Diabetic retinopathy
• Severe gastrointestinal disease
• Pregnancy or plans to become pregnant
• Breastfeeding or planning to breastfeed

Because Ozempic slows stomach emptying, your healthcare provider may also review your other medications to determine whether timing adjustments are needed for certain oral drugs.

Serious Ozempic Side Effects Summary

Serious Side Effect	Frequency	What You Should Do
Pancreatitis	Rare	Stop the medication and seek immediate medical care
Gallbladder disease	Uncommon	Contact your healthcare provider promptly
Kidney injury	Uncommon	Stay hydrated and seek care if vomiting or diarrhea persists
Vision changes	Uncommon	Schedule an eye examination promptly
Severe allergic reaction	Rare	Call 911 or seek emergency care immediately
Thyroid tumor warning	Precaution	Avoid Ozempic if you have MTC or MEN 2

Ozempic vs. Mounjaro: Which Medication Is Better?

Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are two of the most effective injectable medications available for adults with type 2 diabetes. Both are taken once weekly, improve blood sugar control, and often lead to significant weight loss. However, they work differently and may produce different results depending on your individual health goals.

Ozempic belongs to a class of medications called GLP-1 receptor agonists, while Mounjaro is the first medication in a newer class known as a dual GIP and GLP-1 receptor agonist. By activating two hormone pathways involved in blood sugar regulation and appetite, Mounjaro has demonstrated greater average reductions in A1C and body weight in several head-to-head clinical trials.³

That does not necessarily mean Mounjaro is the best choice for everyone. Factors such as insurance coverage, medication tolerance, existing medical conditions, cardiovascular disease, kidney disease, and your healthcare provider’s recommendations all play an important role when selecting treatment.

Ozempic vs. Mounjaro Comparison Table

Feature	Ozempic (Semaglutide)	Mounjaro (Tirzepatide)
Drug Class	GLP-1 receptor agonist	Dual GIP/GLP-1 receptor agonist4
FDA Approval	Type 2 diabetes	Type 2 diabetes
Injection	Once weekly	Once weekly
A1C Reduction	Excellent	Excellent (greater average reduction in studies)
Average Weight Loss	Significant	Generally greater
Common Side Effects	Nausea, diarrhea, constipation, vomiting	Similar gastrointestinal side effects4
Cardiovascular Benefit	Proven cardiovascular risk reduction in eligible patients	Cardiovascular benefit demonstrated in SURPASS-CVOT; FDA-approved for cardiovascular risk reduction in eligible adults with type 2 diabetes.5
Kidney Benefits	Approved for certain adults with diabetic chronic kidney disease	Ongoing research in kidney outcomes
FDA Boxed Warning	Thyroid C-cell tumors (animal studies)	Thyroid C-cell tumors (animal studies)

Bottom line: Both medications are highly effective, but Mounjaro generally produces larger average reductions in A1C and body weight in clinical trials. Your healthcare provider can help determine which medication best fits your health needs.

Blood Sugar Effectiveness

The American Diabetes Association (ADA) identifies semaglutide and tirzepatide among the highest-efficacy therapies for glucose lowering and weight loss in adults with type 2 diabetes.⁶

Clinical studies have shown that both medications can substantially improve glucose control when combined with healthy nutrition and regular physical activity.

As your A1C improves during treatment, our A1C Calculator can help estimate how your average blood glucose relates to your A1C results and track your long-term progress between healthcare visits.

Ozempic

Semaglutide has consistently demonstrated:

• Significant reductions in A1C
• Lower fasting blood glucose
• Reduced post-meal glucose spikes
• Cardiovascular benefits in eligible patients
• Meaningful weight loss

The SUSTAIN clinical trial program established semaglutide as one of the most effective GLP-1 receptor agonists available.

Mounjaro

Tirzepatide builds on these benefits by activating both GLP-1 and GIP receptors.

Clinical trials have demonstrated:

• Larger average A1C reductions than semaglutide³
• Greater weight loss
• Excellent glucose control across multiple starting A1C levels

The SURPASS clinical trial program found that many participants receiving tirzepatide achieved A1C levels below 7%, with some reaching levels below 5.7% depending on dose and study population.

Clinical Insight: Lower A1C values are beneficial only when achieved safely. Treatment goals should always be individualized based on age, other medical conditions, hypoglycemia risk, and overall health.⁶

Weight-Loss Evidence

Although Ozempic is approved to improve blood sugar control rather than specifically for weight management, many people lose weight while taking the medication because it reduces appetite and slows stomach emptying.

Ozempic (SUSTAIN Trials)

Across the SUSTAIN clinical trials, participants receiving semaglutide experienced:

• Significant weight reduction
• Improved A1C
• Lower cardiovascular risk in eligible patients⁷
• Better overall metabolic health

Weight loss varies considerably from person to person and depends on factors such as diet, physical activity, medication adherence, and the prescribed dose.

Mounjaro (SURPASS Trials)

The SURPASS studies demonstrated even greater average weight loss than semaglutide.

Compared with Ozempic, many participants taking tirzepatide experienced:

• Larger reductions in body weight
• Greater decreases in waist circumference
• Larger A1C improvements
• Higher percentages achieving ambitious weight-loss goals³

Because tirzepatide activates two hormone pathways involved in appetite regulation, many experts believe this dual mechanism contributes to its greater average weight-loss effects.

Average Clinical Outcomes

Outcome	Ozempic	Mounjaro
Blood Sugar Control	Excellent	Excellent (greater average reduction)
Weight Loss	Significant	Generally greater
Weekly Injection	Yes	Yes
Cardiovascular Benefits	Established for eligible patients	Cardiovascular benefit established5
Common GI Side Effects	Yes	Yes

Cost Considerations

Prescription medication costs change frequently because of insurance formularies, pharmacy pricing, manufacturer savings programs, and regional availability.

For that reason, exact prices quickly become outdated.

Instead of focusing on list prices, consider these factors when comparing Ozempic and Mounjaro.

What Influences Cost?

• Health insurance coverage
• Medicare or Medicaid eligibility
• Manufacturer savings programs
• Pharmacy pricing
• Prescribed dosage
• Prior authorization requirements
• Availability in your area

Many commercial insurance plans cover one medication but not the other, making insurance coverage one of the largest factors affecting out-of-pocket costs.

Before switching medications, contact your insurance provider or pharmacist to determine:

• Which medication is preferred by your plan
• Whether prior authorization is required
• Your estimated monthly copay
• Whether manufacturer savings programs are available

Money-Saving Tip: The lowest list price is not always the lowest out-of-pocket cost. Insurance coverage and manufacturer savings cards often have a much greater impact on what you’ll actually pay.

Should You Choose Ozempic or Mounjaro?

Every person’s diabetes treatment plan is different.

The following table summarizes situations where one medication may be more appropriate than the other. Final treatment decisions should always be made with your healthcare provider.

Your Priority	Medication Often Considered
Improve blood sugar control	Either medication
Maximize weight loss	Mounjaro may provide greater average weight loss
Established cardiovascular benefit	Ozempic has extensive cardiovascular outcomes data
Chronic kidney disease with diabetes	Ozempic may be appropriate for eligible patients
Sensitive stomach	Individual tolerance varies
Insurance coverage	Often determines the most practical choice

Remember that both medications require healthy eating habits, regular physical activity, and ongoing medical follow-up to achieve the best long-term results.

Frequently Asked Questions About Ozempic Side Effects

Conclusion

Ozempic has transformed the treatment of type 2 diabetes by helping many people achieve better blood sugar control while also supporting meaningful weight loss. Like any prescription medication, it comes with potential side effects, but most are mild, temporary, and improve as treatment continues.

Serious complications—including pancreatitis, gallbladder disease, kidney injury, severe allergic reactions, and the boxed warning regarding thyroid C-cell tumors—are uncommon but should be recognized early. Understanding these risks allows you to seek prompt medical care if concerning symptoms develop.

When compared with Mounjaro, both medications are highly effective options for managing type 2 diabetes. Mounjaro has demonstrated greater average reductions in A1C and body weight in clinical trials, while Ozempic has extensive evidence supporting cardiovascular benefits and additional approved indications for eligible patients with chronic kidney disease.

The best medication is ultimately the one that aligns with your individual health goals, medical history, insurance coverage, and your healthcare provider’s recommendations. Regular follow-up appointments, healthy lifestyle habits, and open communication with your care team remain essential for achieving safe, long-term diabetes management.

References

1. U.S. Food and Drug Administration. Ozempic (semaglutide) Prescribing Information. Revised January 2025. [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩]
2. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. Revised August 2025. [↩]
3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021;385:503–515. [↩] [↩] [↩]
4. U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. Revised January 2026. [↩] [↩]
5. Nicholls SJ, Pavo I, Bhatt DL, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. New England Journal of Medicine. 2025;393:2409–2420. [↩] [↩]
6. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl. 1):S183–S215. [↩] [↩]
7. Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 2016;375:1834–1844. [↩]